Anti-candidal activities of lactoferrin in systemic candidiasis

Kabilan Velliyagounder, Mariam Aldajani

Research output: Chapter in Book/Report/Conference proceedingChapter


Candida albicans, the most prevalent fungal biofilm-forming pathogen, is responsible for several types of oral and systemic infections. Several studies have reported resistant strains of C. albicans, due to the recurrent episodes of oral thrush and prolonged use of azole antibiotics. During disseminated infection, candida hyphae invade mucosal epithelial cells and target organs, particularly the kidney. Death from candidemia results from renal insufficiency in a substantial number of patients. The lack of effective treatment against resistant strains of C. albicans is a major constraint in successfully treating these patients. Therefore, there is an urgent need to develop better therapeutic and prophylactic strategies to combat these fatal infections. Lactoferrin is a host defense factor, present in saliva, neutrophils and milk, which exhibit anti-candidal activities against C. albicans in vitro and in vivo. However, the underlying mechanisms by which human lactoferrin (hLF) mediate host defenses against systemic candidiasis, are not known. In the present report, the literature on the current epidemiology, pathogenicity, antifungal resistance of candida species, as well as new therapies for systemic infection including hLF, is reviewed.

Original languageEnglish (US)
Title of host publicationLactoferrin
Subtitle of host publicationStructure, Biological Functions, Health Benefits and Clinical Applications
PublisherNova Science Publishers, Inc.
Number of pages26
ISBN (Electronic)9781536127041
ISBN (Print)9781536127034
StatePublished - Jan 1 2017

All Science Journal Classification (ASJC) codes

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)


Dive into the research topics of 'Anti-candidal activities of lactoferrin in systemic candidiasis'. Together they form a unique fingerprint.

Cite this